BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

645 related articles for article (PubMed ID: 26988913)

  • 1. Activation of mesenchymal stem cells by macrophages promotes tumor progression through immune suppressive effects.
    Jia XH; Feng GW; Wang ZL; Du Y; Shen C; Hui H; Peng D; Li ZJ; Kong DL; Tian J
    Oncotarget; 2016 Apr; 7(15):20934-44. PubMed ID: 26988913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mesenchymal stem cells and macrophages interact through IL-6 to promote inflammatory breast cancer in pre-clinical models.
    Wolfe AR; Trenton NJ; Debeb BG; Larson R; Ruffell B; Chu K; Hittelman W; Diehl M; Reuben JM; Ueno NT; Woodward WA
    Oncotarget; 2016 Dec; 7(50):82482-82492. PubMed ID: 27756885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor-associated macrophages promote cancer stem cell-like properties via transforming growth factor-beta1-induced epithelial-mesenchymal transition in hepatocellular carcinoma.
    Fan QM; Jing YY; Yu GF; Kou XR; Ye F; Gao L; Li R; Zhao QD; Yang Y; Lu ZH; Wei LX
    Cancer Lett; 2014 Oct; 352(2):160-8. PubMed ID: 24892648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor-associated macrophages produce interleukin 6 and signal via STAT3 to promote expansion of human hepatocellular carcinoma stem cells.
    Wan S; Zhao E; Kryczek I; Vatan L; Sadovskaya A; Ludema G; Simeone DM; Zou W; Welling TH
    Gastroenterology; 2014 Dec; 147(6):1393-404. PubMed ID: 25181692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanoliposome C6-Ceramide Increases the Anti-tumor Immune Response and Slows Growth of Liver Tumors in Mice.
    Li G; Liu D; Kimchi ET; Kaifi JT; Qi X; Manjunath Y; Liu X; Deering T; Avella DM; Fox T; Rockey DC; Schell TD; Kester M; Staveley-O'Carroll KF
    Gastroenterology; 2018 Mar; 154(4):1024-1036.e9. PubMed ID: 29408569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A double feedback loop mediated by microRNA-23a/27a/24-2 regulates M1 versus M2 macrophage polarization and thus regulates cancer progression.
    Ma S; Liu M; Xu Z; Li Y; Guo H; Ge Y; Liu Y; Zheng D; Shi J
    Oncotarget; 2016 Mar; 7(12):13502-19. PubMed ID: 26540574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatocellular carcinoma cells and their fibrotic microenvironment modulate bone marrow-derived mesenchymal stromal cell migration in vitro and in vivo.
    Garcia MG; Bayo J; Bolontrade MF; Sganga L; Malvicini M; Alaniz L; Aquino JB; Fiore E; Rizzo MM; Rodriguez A; Lorenti A; Andriani O; Podhajcer O; Mazzolini G
    Mol Pharm; 2011 Oct; 8(5):1538-48. PubMed ID: 21770423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TNF-α derived from M2 tumor-associated macrophages promotes epithelial-mesenchymal transition and cancer stemness through the Wnt/β-catenin pathway in SMMC-7721 hepatocellular carcinoma cells.
    Chen Y; Wen H; Zhou C; Su Q; Lin Y; Xie Y; Huang Y; Qiu Q; Lin J; Huang X; Tan W; Min C; Wang C
    Exp Cell Res; 2019 May; 378(1):41-50. PubMed ID: 30844387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL-6 promotes PD-L1 expression in monocytes and macrophages by decreasing protein tyrosine phosphatase receptor type O expression in human hepatocellular carcinoma.
    Zhang W; Liu Y; Yan Z; Yang H; Sun W; Yao Y; Chen Y; Jiang R
    J Immunother Cancer; 2020 Jun; 8(1):. PubMed ID: 32581055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human breast cancer cells educate macrophages toward the M2 activation status.
    Sousa S; Brion R; Lintunen M; Kronqvist P; Sandholm J; Mönkkönen J; Kellokumpu-Lehtinen PL; Lauttia S; Tynninen O; Joensuu H; Heymann D; Määttä JA
    Breast Cancer Res; 2015 Aug; 17(1):101. PubMed ID: 26243145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Zoledronic acid prevents the tumor-promoting effects of mesenchymal stem cells via MCP-1 dependent recruitment of macrophages.
    Jia XH; Du Y; Mao D; Wang ZL; He ZQ; Qiu JD; Ma XB; Shang WT; Ding D; Tian J
    Oncotarget; 2015 Sep; 6(28):26018-28. PubMed ID: 26305552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inflammatory microenvironment and expression of chemokines in hepatocellular carcinoma.
    Han KQ; He XQ; Ma MY; Guo XD; Zhang XM; Chen J; Han H; Zhang WW; Zhu QG; Nian H; Ma LJ
    World J Gastroenterol; 2015 Apr; 21(16):4864-74. PubMed ID: 25944999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SIRT4 silencing in tumor-associated macrophages promotes HCC development via PPARδ signalling-mediated alternative activation of macrophages.
    Li Z; Li H; Zhao ZB; Zhu W; Feng PP; Zhu XW; Gong JP
    J Exp Clin Cancer Res; 2019 Nov; 38(1):469. PubMed ID: 31744516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mesenchymal stem cells alter macrophage immune responses to Leishmania major infection in both susceptible and resistance mice.
    Dameshghi S; Zavaran-Hosseini A; Soudi S; Shirazi FJ; Nojehdehi S; Hashemi SM
    Immunol Lett; 2016 Feb; 170():15-26. PubMed ID: 26703818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemokine expression profile of freshly isolated human glioblastoma-associated macrophages/microglia.
    Hattermann K; Sebens S; Helm O; Schmitt AD; Mentlein R; Mehdorn HM; Held-Feindt J
    Oncol Rep; 2014 Jul; 32(1):270-6. PubMed ID: 24859792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blocking Triggering Receptor Expressed on Myeloid Cells-1-Positive Tumor-Associated Macrophages Induced by Hypoxia Reverses Immunosuppression and Anti-Programmed Cell Death Ligand 1 Resistance in Liver Cancer.
    Wu Q; Zhou W; Yin S; Zhou Y; Chen T; Qian J; Su R; Hong L; Lu H; Zhang F; Xie H; Zhou L; Zheng S
    Hepatology; 2019 Jul; 70(1):198-214. PubMed ID: 30810243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TFEB is a master regulator of tumor-associated macrophages in breast cancer.
    Li Y; Hodge J; Liu Q; Wang J; Wang Y; Evans TD; Altomare D; Yao Y; Murphy EA; Razani B; Fan D
    J Immunother Cancer; 2020 Jun; 8(1):. PubMed ID: 32487570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lysosomal acid lipase in mesenchymal stem cell stimulation of tumor growth and metastasis.
    Zhao T; Yan C; Du H
    Oncotarget; 2016 Sep; 7(38):61121-61135. PubMed ID: 27531897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combretastatin A-1 phosphate, a microtubule inhibitor, acts on both hepatocellular carcinoma cells and tumor-associated macrophages by inhibiting the Wnt/β-catenin pathway.
    Mao J; Wang D; Wang Z; Tian W; Li X; Duan J; Wang Y; Yang H; You L; Cheng Y; Bian J; Chen Z; Yang Y
    Cancer Lett; 2016 Sep; 380(1):134-43. PubMed ID: 27349166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor-associated macrophages exhibit pro- and anti-inflammatory properties by which they impact on pancreatic tumorigenesis.
    Helm O; Held-Feindt J; Grage-Griebenow E; Reiling N; Ungefroren H; Vogel I; Krüger U; Becker T; Ebsen M; Röcken C; Kabelitz D; Schäfer H; Sebens S
    Int J Cancer; 2014 Aug; 135(4):843-61. PubMed ID: 24458546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.